Riskpilot← Back to searchSign inGet full accessSANDE DYREKLINIKK AS
ASActiveOrg 925198501Revåveien 5, 3070 Sande I VestfoldVeterinary activities · NACE 7500Est. 20208 employees
Revenue 2024
NOK 9,6M
+22% vs 2023
EBITDA margin
5.9%
-37% vs 2023
Equity ratio
23.6%
Financial strength
Net profit 2024
NOK -27K
-113% vs 2023
| Revenue | NOK 9,6M | +22% |
| EBITDA | NOK 570K | -37% |
| Net profit | NOK -27K | -113% |
| Total assets | NOK 4,5M | +7% |
| Equity | NOK 1,1M | -2% |
| Employees | 8 | — |
Legal name
SANDE DYREKLINIKK AS
Org number
925198501
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
15. juni 2020
Share capital
NOK 100 000
Employees
8 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Drive dyreklinikk og veterinærtjenester, samt salg av varer, utstyr og tjenester i tilknytning til denne type virksomhet.
Address
Revåveien 5, 3070 Sande I Vestfold
Phone
+4733778005
Email
post@sandedyreklinikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 913 | 4 774 | 6 920 | 7 929 | 9 639 |
| Staff expenses | −457 | −1 910 | −3 310 | −3 829 | −5 220 |
| EBITDA | −13 | 1 142 | 1 093 | 902 | 570 |
| Depreciation & amort. | −69 | −213 | −256 | −587 | −501 |
| EBIT | −83 | 929 | 837 | 315 | 69 |
| Net financials | −3 | −7 | −10 | −49 | −98 |
| Profit before tax | −86 | 922 | 828 | 266 | −29 |
| Tax | −20 | 203 | 182 | 58 | −1 |
| Net profit | −66 | 719 | 645 | 207 | −27 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 095 | 1 681 | 2 543 | 4 237 | 4 542 |
| Equity | 29 | 248 | 893 | 1 100 | 1 073 |
| Long-term debt | 0 | 58 | 55 | 49 | 0 |
| Short-term debt | 2 066 | 1 375 | 1 595 | 3 088 | 3 468 |
| Total debt | 2 066 | 1 434 | 1 649 | 3 136 | 3 468 |
EBITDA margin
5.9%
This company
15.8%
Market median
-63% vs market
20202024
Equity ratio
23.6%
This company
38.2%
Market median
-38% vs market
20202024
Return on equity
-2.5%
This company
18.4%
Market median
-114% vs market
20202024
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20202024
Asset turnover
2.12×
This company
1.12×
Market median
+89% vs market
20202024
Debt / equity
3.23×
This company
0.62×
Market median
-421% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-06-04 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ÅM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SANDE DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åse Marie Skjeggedal Borgen | Chief Executive Officer | 0 companies |
| Trygve Borgen | Chairman | 0 companies |